{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:21:54Z","timestamp":1786335714456,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS103075-01A1"],"award-info":[{"award-number":["R21NS103075-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK55704"],"award-info":[{"award-number":["R01DK55704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"crossref","award":["RG1506-04717"],"award-info":[{"award-number":["RG1506-04717"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD26979"],"award-info":[{"award-number":["HD26979"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Child Health and Disease","award":["1 R21 NS103075-01A1"],"award-info":[{"award-number":["1 R21 NS103075-01A1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intrauterine growth restriction (IUGR) is a common complication of pregnancy and is associated with significant neurological deficits in infants, including white matter damage. Previous work using an animal model of IUGR has demonstrated that IUGR rats exhibit neurobehavioral deficits and developmental delays in oligodendrocyte maturation and myelination, but the mechanisms which cause this delay are unknown. Inflammation may be an important etiological factor in IUGR and has been recognized as playing a fundamental role in the pathogenesis of myelin disorders, including cerebral palsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To create the model, the uterine arteries of pregnant rats were ligated at embryonic day 15. Rats delivered spontaneously. Cytokine and chemokine expression was evaluated at one prenatal and three postnatal time points, and myelin protein expression and oligodendrocyte cell numbers were evaluated by several methods at postnatal day 14. IL-4 was identified as a potential inhibitor of myelination, and rat pups were injected with IL-4 function blocking antibody from postnatal days 1\u20135 and myelination was assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here, we show a novel mechanism of white matter injury. IUGR induces an exaggerated Th2 response in the developing rat brain, including upregulation of several Th2 cytokines. Of these, IL-4 is significantly increased during the period corresponding to robust developmental myelination. We show that neutralizing IL-4 antibody therapy given in the newborn period ameliorates inflammation and restores myelin protein expression and oligodendrocyte cell number in the IUGR brain to control levels, demonstrating a novel role for Th2 responses and IL-4 in IUGR and white matter injury. In addition, IL-4 directly affects oligodendrocytes in vitro decreasing differentiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this study, we have identified inflammation as a factor in the decrease in myelin seen in an animal model of IUGR. IL-4, an inflammatory protein often thought to be protective in the adult, is specifically increased, and treatment of these animals to prevent this increase ameliorates white matter damage. Our results suggest that the immune system plays a role in IUGR that is different in the perinatal period than in the adult and preventing this exaggerated Th2 response may be a potential therapeutic target.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s11689-019-9297-6","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T01:02:20Z","timestamp":1576458140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Reducing Th2 inflammation through neutralizing IL-4 antibody rescues myelination in IUGR rat brain"],"prefix":"10.1186","volume":"11","author":[{"given":"Allison E.","family":"Zanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah A.","family":"Romer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lane","family":"Jaeckle-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-5314","authenticated-orcid":false,"given":"Judith B.","family":"Grinspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"issue":"5","key":"9297_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jnen\/62.5.441","volume":"62","author":"RL Haynes","year":"2003","unstructured":"Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol. 2003;62(5):441\u201350.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"9297_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.brainres.2006.08.004","volume":"1117","author":"R Geva","year":"2006","unstructured":"Geva R, Eshel R, Leitner Y, Fattal-Valevski A, Harel S. Memory functions of children born with asymmetric intrauterine growth restriction. Brain Res. 2006;1117(1):186\u201394.","journal-title":"Brain Res"},{"issue":"10","key":"9297_CR3","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1471-0528.2008.01827.x","volume":"115","author":"B Jacobsson","year":"2008","unstructured":"Jacobsson B, Ahlin K, Francis A, Hagberg G, Hagberg H, Gardosi J. Cerebral palsy and restricted growth status at birth: population-based case-control study. BJOG. 2008;115(10):1250\u20135.","journal-title":"BJOG."},{"issue":"11","key":"9297_CR4","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/j.1651-2227.2007.00496.x","volume":"96","author":"NF Padilla-Gomes","year":"2007","unstructured":"Padilla-Gomes NF, Enriquez G, Acosta-Rojas R, Perapoch J, Hernandez-Andrade E, Gratacos E. Prevalence of neonatal ultrasound brain lesions in premature infants with and without intrauterine growth restriction. Acta Paediatr. 2007;96(11):1582\u20137.","journal-title":"Acta Paediatr"},{"issue":"7","key":"9297_CR5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/NEN.0b013e31825cfa81","volume":"71","author":"MV Reid","year":"2012","unstructured":"Reid MV, Murray KA, Marsh ED, Golden JA, Simmons RA, Grinspan JB. Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol. 2012;71(7):640\u201353.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"9297_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1750-3639.2007.00107.x","volume":"18","author":"SS Billiards","year":"2008","unstructured":"Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, Rowitch DH, et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 2008;18(2):153\u201363.","journal-title":"Brain Pathol"},{"issue":"10","key":"9297_CR7","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1111\/apa.12339","volume":"102","author":"TF McElrath","year":"2013","unstructured":"McElrath TF, Allred EN, Van Marter L, Fichorova RN, Leviton A, Investigators ES. Perinatal systemic inflammatory responses of growth-restricted preterm newborns. Acta Paediatr. 2013;102(10):e439\u201342.","journal-title":"Acta Paediatr"},{"issue":"2","key":"9297_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1055\/s-0033-1334879","volume":"225","author":"U Lindner","year":"2013","unstructured":"Lindner U, Tutdibi E, Binot S, Monz D, Hilgendorff A, Gortner L. Levels of cytokines in umbilical cord blood in small for gestational age preterm infants. Klin Padiatr. 2013;225(2):70\u20134.","journal-title":"Klin Padiatr"},{"issue":"1","key":"9297_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-012-9657-y","volume":"27","author":"L Duijts","year":"2012","unstructured":"Duijts L. Fetal and infant origins of asthma. Eur J Epidemiol. 2012;27(1):5\u201314.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"9297_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00001648-200003000-00018","volume":"11","author":"FH Steffensen","year":"2000","unstructured":"Steffensen FH, Sorensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, et al. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology. 2000;11(2):185\u20138.","journal-title":"Epidemiology."},{"issue":"5","key":"9297_CR11","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.2337\/db13-1226","volume":"63","author":"LJ Jaeckle Santos","year":"2014","unstructured":"Jaeckle Santos LJ, Li C, Doulias PT, Ischiropoulos H, Worthen GS, Simmons RA. Neutralizing Th2 inflammation in neonatal islets prevents beta-cell failure in adult IUGR rats. Diabetes. 2014;63(5):1672\u201384.","journal-title":"Diabetes."},{"issue":"2\u20133","key":"9297_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/08830180009088503","volume":"19","author":"B Adkins","year":"2000","unstructured":"Adkins B. Development of neonatal Th1\/Th2 function. Int Rev Immunol. 2000;19(2\u20133):157\u201371.","journal-title":"Int Rev Immunol"},{"issue":"5","key":"9297_CR13","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.4049\/jimmunol.178.5.2667","volume":"178","author":"S Rose","year":"2007","unstructured":"Rose S, Lichtenheld M, Foote MR, Adkins B. Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol. 2007;178(5):2667\u201378.","journal-title":"J Immunol"},{"issue":"1","key":"9297_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0033-1361823","volume":"32","author":"SG Kallapur","year":"2014","unstructured":"Kallapur SG, Presicce P, Rueda CM, Jobe AH, Chougnet CA. Fetal immune response to chorioamnionitis. Semin Reprod Med. 2014;32(1):56\u201367.","journal-title":"Semin Reprod Med"},{"issue":"1","key":"9297_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/ana.10764","volume":"55","author":"B Cannella","year":"2004","unstructured":"Cannella B, Raine CS. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol. 2004;55(1):46\u201357.","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"9297_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0006-8993(00)02398-2","volume":"870","author":"AE Lovett-Racke","year":"2000","unstructured":"Lovett-Racke AE, Smith ME, Arredondo LR, Bittner PS, Ratts RB, Shive CL, et al. Developmentally regulated gene expression of Th2 cytokines in the brain. Brain Res. 2000;870(1\u20132):27\u201335.","journal-title":"Brain Res"},{"issue":"9","key":"9297_CR17","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.4049\/jimmunol.1202246","volume":"189","author":"SP Gadani","year":"2012","unstructured":"Gadani SP, Cronk JC, Norris GT, Kipnis J. IL-4 in the brain: a cytokine to remember. J Immunol. 2012;189(9):4213\u20139.","journal-title":"J Immunol"},{"issue":"40","key":"9297_CR18","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1523\/JNEUROSCI.1922-07.2007","volume":"27","author":"ED Ponomarev","year":"2007","unstructured":"Ponomarev ED, Maresz K, Tan Y, Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci. 2007;27(40):10714\u201321.","journal-title":"J Neurosci"},{"issue":"1","key":"9297_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.10050","volume":"38","author":"S Hulshof","year":"2002","unstructured":"Hulshof S, Montagne L, De Groot CJ, Van Der Valk P. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia. 2002;38(1):24\u201335.","journal-title":"Glia."},{"issue":"10","key":"9297_CR20","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2337\/diabetes.50.10.2279","volume":"50","author":"RA Simmons","year":"2001","unstructured":"Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes. 2001;50(10):2279\u201386.","journal-title":"Diabetes."},{"issue":"1","key":"9297_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jnr.21462","volume":"86","author":"J Ara","year":"2008","unstructured":"Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, et al. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J Neurosci Res. 2008;86(1):125\u201335.","journal-title":"J Neurosci Res"},{"key":"9297_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mcn.2009.07.010","volume":"42","author":"K Feigenson","year":"2009","unstructured":"Feigenson K, Reid M, See J, Crenshaw EB II, Grinspan JB. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci. 2009;42:255\u201365.","journal-title":"Mol Cell Neurosci"},{"key":"9297_CR23","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/j.1471-4159.1991.tb06367.x","volume":"57","author":"M Yamada","year":"1991","unstructured":"Yamada M, Konola JT, Wekerle H, Lees MB. Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants. J Neurochem. 1991;57:1671\u201380.","journal-title":"J Neurochem"},{"key":"9297_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1083\/jcb.85.3.890","volume":"85","author":"KD McCarthy","year":"1980","unstructured":"McCarthy KD, De Vellis J. Preparation of separate astroglial and oligodendroglial cultures from rat cerebral tissue. J Cell Biol. 1980;85:890\u2013902.","journal-title":"J Cell Biol"},{"key":"9297_CR25","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1073\/pnas.79.8.2709","volume":"79","author":"B Ranscht","year":"1982","unstructured":"Ranscht B, Clapschaw PA, Price J, Noble M, Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci U S A. 1982;79:2709\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9297_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0165-5728(00)00455-0","volume":"113","author":"H Hackstein","year":"2001","unstructured":"Hackstein H, Bitsch A, Bohnert A, Hofmann H, Weber F, Ohly A, et al. Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis. J Neuroimmunol. 2001;113(2):240\u20138.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"9297_CR27","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1007\/s12035-015-9443-4","volume":"53","author":"Ana Paula Kallaur","year":"2015","unstructured":"Kallaur AP, Lopes J, Oliveira SR, Simao AN, Reiche EM, de Almeida ER, et al. Immune-inflammatory and oxidative and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: increased peripheral inflammation but less acute neuroinflammation. Mol Neurobiol. 2015;53(8):5191\u20135202.","journal-title":"Molecular Neurobiology"},{"issue":"12","key":"9297_CR28","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/glia.23079","volume":"64","author":"A Rideau Batista Novais","year":"2016","unstructured":"Rideau Batista Novais A, Pham H, Van de Looij Y, Bernal M, Mairesse J, Zana-Taieb E, et al. Transcriptomic regulations in oligodendroglial and microglial cells related to brain damage following fetal growth restriction. Glia. 2016;64(12):2306\u201320.","journal-title":"Glia."},{"issue":"4","key":"9297_CR29","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1542\/peds.2010-2442","volume":"127","author":"I Guellec","year":"2011","unstructured":"Guellec I, Lapillonne A, Renolleau S, Charlaluk ML, Roze JC, Marret S, et al. Neurologic outcomes at school age in very preterm infants born with severe or mild growth restriction. Pediatrics. 2011;127(4):e883\u201391.","journal-title":"Pediatrics."},{"issue":"5","key":"9297_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1471-0528.2008.02081.x","volume":"116","author":"L Carbillon","year":"2009","unstructured":"Carbillon L. Cerebral palsy and restricted growth status at birth: population-based case-control study. BJOG. 2009;116(5):735\u20136 author reply 6.","journal-title":"BJOG."},{"issue":"2\u20133","key":"9297_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000346682","volume":"35","author":"S Falahati","year":"2013","unstructured":"Falahati S, Breu M, Waickman AT, Phillips AW, Arauz EJ, Snyder S, et al. Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia. Dev Neurosci. 2013;35(2\u20133):182\u201396.","journal-title":"Dev Neurosci"},{"issue":"1","key":"9297_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.nbd.2007.01.001","volume":"26","author":"P Olivier","year":"2007","unstructured":"Olivier P, Baud O, Bouslama M, Evrard P, Gressens P, Verney C. Moderate growth restriction: deleterious and protective effects on white matter damage. Neurobiol Dis. 2007;26(1):253\u201363.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"9297_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2011.08.002","volume":"232","author":"M Tolcos","year":"2011","unstructured":"Tolcos M, Bateman E, O'Dowd R, Markwick R, Vrijsen K, Rehn A, et al. Intrauterine growth restriction affects the maturation of myelin. Exp Neurol. 2011;232(1):53\u201365.","journal-title":"Exp Neurol"},{"issue":"6","key":"9297_CR34","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/0896-6273(94)90451-0","volume":"12","author":"S Scherer","year":"1994","unstructured":"Scherer S, Braun P, Grinspan J, Collarini E, Wang D-Y, Kamholz J. Differential regulation of the 2\u20323\u2032-cyclic nucleotide 3\u2032-phosphodiesterase gene in oligodendrocyte development. Neuron. 1994;12(6):1363\u201375.","journal-title":"Neuron"},{"issue":"32","key":"9297_CR35","doi-asserted-by":"publisher","first-page":"11281","DOI":"10.1523\/JNEUROSCI.1685-15.2015","volume":"35","author":"X Zhao","year":"2015","unstructured":"Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J. Neuronal Interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci. 2015;35(32):11281\u201391.","journal-title":"J Neurosci"},{"issue":"2","key":"9297_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/STROKEAHA.115.012079","volume":"47","author":"X Liu","year":"2016","unstructured":"Liu X, Liu J, Zhao S, Zhang H, Cai W, Cai M, et al. Interleukin-4 is essential for microglia\/macrophage M2 polarization and long-term recovery after cerebral ischemia. Stroke. 2016;47(2):498\u2013504.","journal-title":"Stroke."},{"key":"9297_CR37","first-page":"61","volume":"10","author":"J Yang","year":"2016","unstructured":"Yang J, Ding S, Huang W, Hu J, Huang S, Zhang Y, et al. Interleukin-4 ameliorates the functional recovery of Intracerebral hemorrhage through the alternative activation of microglia\/macrophage. Front Neurosci. 2016;10:61.","journal-title":"Front Neurosci"},{"issue":"1","key":"9297_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mcn.2005.10.006","volume":"31","author":"O Butovsky","year":"2006","unstructured":"Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem\/progenitor cells. Mol Cell Neurosci. 2006;31(1):149\u201360.","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"9297_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI26836","volume":"116","author":"O Butovsky","year":"2006","unstructured":"Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest. 2006;116(4):905\u201315.","journal-title":"J Clin Invest"},{"issue":"12","key":"9297_CR40","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/glia.22887","volume":"63","author":"T Umekawa","year":"2015","unstructured":"Umekawa T, Osman AM, Han W, Ikeda T, Blomgren K. Resident microglia, rather than blood-derived macrophages, contribute to the earlier and more pronounced inflammatory reaction in the immature compared with the adult hippocampus after hypoxia-ischemia. Glia. 2015;63(12):2220\u201330.","journal-title":"Glia."},{"key":"9297_CR41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbi.2017.05.020","volume":"65","author":"Melanie Lalancette-H\u00e9bert","year":"2017","unstructured":"Lalancette-Hebert M, Faustino J, Thammisetty SS, Chip S, Vexler ZS, Kriz J. Live imaging of the innate immune response in neonates reveals differential TLR2 dependent activation patterns in sterile inflammation and infection. Brain Behav Immun. 2017;65:312\u201327.","journal-title":"Brain, Behavior, and Immunity"},{"issue":"3","key":"9297_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1871527311312030007","volume":"12","author":"P Ferrazzano","year":"2013","unstructured":"Ferrazzano P, Chanana V, Uluc K, Fidan E, Akture E, Kintner DB, et al. Age-dependent microglial activation in immature brains after hypoxia- ischemia. CNS Neurol Disord Drug Targets. 2013;12(3):338\u201349.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1-4","key":"9297_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000477490","volume":"39","author":"Brian H. Kim","year":"2017","unstructured":"Kim BH, Guardia Clausi M, Frondelli M, Nnah IC, Saqcena C, Dobrowolski R, et al. Age-dependent effects of ALK5 inhibition and mechanism of neuroprotection in neonatal hypoxic-ischemic brain injury. Dev Neurosci. 2017;39(1\u20134):338\u201351.","journal-title":"Developmental Neuroscience"},{"key":"9297_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1742-2094-11-70","volume":"11","author":"LB Christensen","year":"2014","unstructured":"Christensen LB, Woods TA, Carmody AB, Caughey B, Peterson KE. Age-related differences in neuroinflammatory responses associated with a distinct profile of regulatory markers on neonatal microglia. J Neuroinflammation. 2014;11:70.","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"9297_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0165-5728(97)00154-9","volume":"81","author":"C Brodie","year":"1998","unstructured":"Brodie C, Goldreich N, Haiman T, Kazimirsky G. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J Neuroimmunol. 1998;81(1\u20132):20\u201330.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"9297_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.0953-816x.2000.01412.x","volume":"13","author":"E Molina-Holgado","year":"2001","unstructured":"Molina-Holgado E, Vela JM, Arevalo-Martin A, Guaza C. LPS\/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci. 2001;13(3):493\u2013502.","journal-title":"Eur J Neurosci"},{"issue":"7","key":"9297_CR47","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.4049\/jimmunol.176.7.4385","volume":"176","author":"AS Paintlia","year":"2006","unstructured":"Paintlia AS, Paintlia MK, Singh I, Singh AK. IL-4-induced peroxisome proliferator-activated receptor gamma activation inhibits NF-kappaB trans activation in central nervous system (CNS) glial cells and protects oligodendrocyte progenitors under neuroinflammatory disease conditions: implication for CNS-demyelinating diseases. J Immunol. 2006;176(7):4385\u201398.","journal-title":"J Immunol"},{"key":"9297_CR48","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1101\/gad.1806309","volume":"23","author":"SP Fancy","year":"2009","unstructured":"Fancy SP, Barazini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 2009;23:1571\u201385.","journal-title":"Genes Dev"},{"issue":"10","key":"9297_CR49","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/nm781","volume":"8","author":"GR John","year":"2002","unstructured":"John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med. 2002;8(10):1115\u201321.","journal-title":"Nat Med"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-019-9297-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s11689-019-9297-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-019-9297-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:12:03Z","timestamp":1607991123000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-019-9297-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9297"],"URL":"https:\/\/doi.org\/10.1186\/s11689-019-9297-6","relation":{},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"10 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed in accordance with the guidelines set forth by The Children\u2019s Hospital of Philadelphia Institutional Animal Care and Use Committee (current approval: IAC 16-000025). No work on humans was included in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No human studies were conducted for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}